Annual Shareholders Equity
$253.11 M
+$3.63 M+1.46%
December 31, 2023
Summary
- As of February 26, 2025, TNGX annual stockholders equity is $253.11 million, with the most recent change of +$3.63 million (+1.46%) on December 31, 2023.
- During the last 3 years, TNGX annual shareholders equity has risen by +$214.51 million (+555.72%).
- TNGX annual shareholders equity is now -26.58% below its all-time high of $344.75 million, reached on December 31, 2021.
Performance
TNGX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$229.17 M
-$18.50 M-7.47%
September 30, 2024
Summary
- As of February 26, 2025, TNGX quarterly stockholders equity is $229.17 million, with the most recent change of -$18.50 million (-7.47%) on September 30, 2024.
- Over the past year, TNGX quarterly shareholders equity has stayed the same.
- TNGX quarterly shareholders equity is now -37.28% below its all-time high of $365.41 million, reached on September 30, 2021.
Performance
TNGX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TNGX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.5% | 0.0% |
| 3 y3 years | +555.7% | 0.0% |
| 5 y5 years | +555.7% | 0.0% |
TNGX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.6% | +1.5% | -33.5% | +7.6% |
| 5 y | 5-year | -26.6% | +555.7% | -37.3% | +493.7% |
| alltime | all time | -26.6% | +555.7% | -37.3% | +493.7% |
Tango Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $229.17 M(-7.5%) |
| Jun 2024 | - | $247.67 M(-6.3%) |
| Mar 2024 | - | $264.45 M(+4.5%) |
| Dec 2023 | $253.11 M(+1.5%) | $253.11 M(-8.5%) |
| Sep 2023 | - | $276.60 M(+29.9%) |
| Jun 2023 | - | $212.94 M(-6.3%) |
| Mar 2023 | - | $227.26 M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $249.48 M(-27.6%) | $249.48 M(-8.6%) |
| Sep 2022 | - | $273.07 M(-8.6%) |
| Jun 2022 | - | $298.70 M(-6.8%) |
| Mar 2022 | - | $320.36 M(-7.1%) |
| Dec 2021 | $344.75 M(+793.1%) | $344.75 M(-5.7%) |
| Sep 2021 | - | $365.41 M(+846.7%) |
| Dec 2020 | $38.60 M | $38.60 M |
FAQ
- What is Tango Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Tango Therapeutics?
- What is Tango Therapeutics annual shareholders equity year-on-year change?
- What is Tango Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Tango Therapeutics?
- What is Tango Therapeutics quarterly shareholders equity year-on-year change?
What is Tango Therapeutics annual stockholders equity?
The current annual shareholders equity of TNGX is $253.11 M
What is the all time high annual shareholders equity for Tango Therapeutics?
Tango Therapeutics all-time high annual stockholders equity is $344.75 M
What is Tango Therapeutics annual shareholders equity year-on-year change?
Over the past year, TNGX annual stockholders equity has changed by +$3.63 M (+1.46%)
What is Tango Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TNGX is $229.17 M
What is the all time high quarterly shareholders equity for Tango Therapeutics?
Tango Therapeutics all-time high quarterly stockholders equity is $365.41 M
What is Tango Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TNGX quarterly stockholders equity has changed by $0.00 (0.00%)